Zealand Pharma A/S (ZEAL) — Strategic Asset Allocation Index
Zealand Pharma A/S (ZEAL) has a Strategic Asset Allocation Index of 20.3% as of December 2022. Strategic assets (PP&E of Dkr165.49 Million plus long-term investments of Dkr-) total Dkr165.49 Million, measured against net assets of Dkr815.91 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base.
SAAI
Strategic Assets
PP&E
Net Assets
Zealand Pharma A/S Strategic Asset Allocation Index (2014–2022)
This chart shows how Zealand Pharma A/S's Strategic Asset Allocation Index has evolved across 9 annual periods from 2014 to 2022. As of December 2022, the index stands at 20.3%, representing strategic assets of Dkr165.49 Million against net assets of Dkr815.91 Million DKK. Explore Zealand Pharma A/S (ZEAL) cash flow conversion to assess how effectively this company generates cash.
Annual Strategic Asset Allocation Index for Zealand Pharma A/S (2014–2022)
The table below presents the year-by-year Strategic Asset Allocation Index for Zealand Pharma A/S from 2014 to 2022, covering 9 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For the full company profile including market capitalisation, see Zealand Pharma A/S stock valuation.
| Year | SAAI | Strategic Assets (DKK) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2022 | 20.3% | Dkr165.49 Million | Dkr165.49 Million | Dkr- | Dkr815.91 Million | ▼ -6.5 pp |
| 2021 | 26.8% | Dkr248.35 Million | Dkr221.45 Million | Dkr26.91 Million | Dkr927.80 Million | ▲ +0.6 pp |
| 2020 | 26.1% | Dkr307.60 Million | Dkr213.04 Million | Dkr94.56 Million | Dkr1.18 Billion | ▲ +13.2 pp |
| 2019 | 13.0% | Dkr160.97 Million | Dkr125.34 Million | Dkr35.63 Million | Dkr1.24 Billion | ▲ +8.6 pp |
| 2018 | 4.3% | Dkr48.21 Million | Dkr15.63 Million | Dkr32.58 Million | Dkr1.12 Billion | ▼ -0.5 pp |
| 2017 | 4.8% | Dkr25.42 Million | Dkr16.11 Million | Dkr9.31 Million | Dkr528.47 Million | ▼ -0.1 pp |
| 2016 | 4.9% | Dkr13.64 Million | Dkr13.64 Million | Dkr0.00 | Dkr278.19 Million | ▼ -1.6 pp |
| 2015 | 6.5% | Dkr16.45 Million | Dkr16.45 Million | Dkr- | Dkr252.23 Million | ▼ -0.8 pp |
| 2014 | 7.4% | Dkr18.63 Million | Dkr18.63 Million | Dkr- | Dkr252.83 Million | — |